Aspirin Administration in Unstable Angina
Yes, aspirin should be administered immediately to patients with unstable angina unless there is a contraindication such as aspirin allergy or active gastrointestinal bleeding. 1
Immediate Administration
- Aspirin should be given as soon as possible after symptom onset in patients with suspected unstable angina, ideally within the first hours of presentation 2, 3
- The initial dose should be 75-325 mg daily (non-enteric formulation for faster absorption) 1, 3
- Non-enteric aspirin is preferred for acute presentation to ensure rapid platelet inhibition 3
- Administration can occur in the prehospital setting by EMS providers or even by patient self-administration (160-325 mg chewed) while awaiting emergency services 3, 4
Evidence for Mortality and Morbidity Benefit
The evidence supporting aspirin in unstable angina is robust:
- Aspirin reduces myocardial infarction risk by approximately 51% in patients with unstable angina 5
- Treatment for one year results in a 6.6% absolute reduction in the risk of myocardial infarction, stroke, or death from vascular causes (number needed to treat = 15) 2
- Aspirin combined with heparin reduces MI incidence to 1.6-3% compared to 12% with placebo 6
- Long-term aspirin use is associated with improved survival in population-based cohorts with unstable angina 7
Dosing Strategy
Acute Phase
- Initial dose: 75-325 mg daily for suspected unstable angina 2, 1
- Continue for 18 months at 75 mg daily 2
Long-Term Maintenance
- After 18 months, continue aspirin 75-81 mg daily indefinitely 1
- Following PCI with stenting, 81 mg daily is reasonable in preference to higher maintenance doses 1
Dual Antiplatelet Therapy
Aspirin should be combined with a P2Y12 receptor inhibitor (clopidogrel, prasugrel, or ticagrelor) in patients with unstable angina 1, 8:
- Clopidogrel 75 mg daily or ticagrelor 90 mg twice daily should be added for up to 12 months 1
- Loading doses should be administered if not given before diagnostic angiography 1
- This dual antiplatelet therapy applies whether patients are managed medically or undergo revascularization 1
Contraindications and Alternatives
Absolute Contraindications
- Known aspirin hypersensitivity (hives, facial swelling, asthma, anaphylaxis) 9
- Active gastrointestinal bleeding 3, 9
Alternative Therapy
- Clopidogrel 75 mg daily should be substituted when aspirin is absolutely contraindicated 1, 10, 1
- Alternatively, prasugrel 10 mg daily (in PCI-treated patients) or ticagrelor 90 mg twice daily may be used 1
Aspirin Desensitization
- For patients with aspirin sensitivity requiring PCI and stenting, rapid oral aspirin desensitization protocols can be performed 11
- This allows patients to receive necessary dual antiplatelet therapy despite previous sensitivity 11
Common Pitfalls to Avoid
- Do not delay aspirin administration while awaiting diagnostic confirmation—give it immediately for suspected unstable angina 3, 4
- Do not use enteric-coated aspirin in the acute setting, as absorption is delayed 3
- Do not use dipyridamole as an antiplatelet agent in unstable angina, as it can enhance exercise-induced myocardial ischemia 10
- Do not discontinue aspirin prematurely—it should be continued indefinitely unless contraindications develop 1
- Do not use aspirin alone in moderate-to-high risk patients; add a P2Y12 receptor inhibitor 1, 8
Bleeding Risk Considerations
- The risk of major bleeding with aspirin is lower than the mortality benefit in unstable angina 2
- Age ≥60 years, history of ulcers, concurrent anticoagulation, and alcohol use increase bleeding risk 9
- When aspirin is combined with heparin, serious bleeding occurs in approximately 3.3% of patients versus 1.7% with heparin alone 6
- Despite bleeding risk, the net clinical benefit strongly favors aspirin use given the substantial reduction in MI and death 2, 6, 5